Development of HLA-matched vascular grafts utilizing decellularized human umbilical artery.

doi:10.1016/j.humimm.2018.09.001

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Development of HLA-matched vascular grafts utilizing decellularized human umbilical artery.

Human immunology - 1 Dec 2018

Mallis Panagiotis, Michalopoulos Efstathios, Dinou Amalia, Vlachou Maria Spyropoulou, Panagouli Efrosyni, Papapanagiotou Aggeliki, Kassi Eva, Giokas Catherine Stavropoulos

Abstract excerpt

Worldwide, there is a great need of small diameter vascular grafts that can be used in human disorders such as cardiovascular and peripheral vascular disease. Until now, severe adverse reactions are caused from the use of synthetic or animal derived grafts, while the use of autologous vessels is restricted only in a small number of patients. The limited availability of the vessels might be resolved by the use of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to High-Throughput Nucleotide Sequencing
Share to Histocompatibility Testing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HLA Antigens

Share to Mesenchymal Stem Cells

Source

Open in PubMed

Identifiers

PMID: 30213613
DOI: 10.1016/j.humimm.2018.09.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.